BIOMAT Database Logo BIOMAT Database Logo

[Severe arterial spasm in a patient after treatment with dihydroergotamine heparin]. 1986

I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004087 Dihydroergotamine A 9,10alpha-dihydro derivative of ERGOTAMINE. It is used as a vasoconstrictor, specifically for the therapy of MIGRAINE DISORDERS. Agit,Angionorm,Clavigrenin,D-Tamin Retard L.U.T.,D.H.E. 45,DET MS,DHE-45,DHE-Puren,DHE-Ratiopharm,Dihydergot,Dihydroergotamin AL,Dihydroergotamine Mesylate,Dihydroergotamine Methanesulfonate,Dihydroergotamine-Sandoz,Dihytamin,Erganton,Ergomimet,Ergont,Ergotam Von Ct,Ikaran,Migranal,Orstanorm,Seglor,Tamik,Verladyn,D Tamin Retard L.U.T.,DHE 45,DHE Puren,DHE Ratiopharm,DHE45,Dihydroergotamine Sandoz,Mesylate, Dihydroergotamine,Methanesulfonate, Dihydroergotamine,Von Ct, Ergotam
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000792 Angiography Radiography of blood vessels after injection of a contrast medium. Arteriography,Angiogram,Angiograms,Angiographies,Arteriographies
D001132 Arm The superior part of the upper extremity between the SHOULDER and the ELBOW. Brachium,Upper Arm,Arm, Upper,Arms,Arms, Upper,Brachiums,Upper Arms
D001157 Arterial Occlusive Diseases Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency. Arterial Obstructive Diseases,Arterial Occlusion,Arterial Obstructive Disease,Arterial Occlusions,Arterial Occlusive Disease,Disease, Arterial Obstructive,Disease, Arterial Occlusive,Obstructive Disease, Arterial,Occlusion, Arterial,Occlusive Disease, Arterial

Related Publications

I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Vascular spasm during heparin-dihydroergotamine prophylaxis.
July 1987, Clinical pharmacy,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Vascular spasm during thromboembolism prophylaxis with heparin-dihydroergotamine.
July 1982, Lancet (London, England),
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
[Phlebitis with arterial spasm, heparin therapy].
January 1950, Lille chirurgical,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
[Vasospastic reactions after heparin-dihydroergotamine].
September 1982, Deutsche medizinische Wochenschrift (1946),
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Severe reversible arterial spasm with ergotamine.
January 1995, The British journal of clinical practice,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
[Arterial vasospasm as a complication of the prevention of thromboembolism with heparin-dihydroergotamine and its treatment].
January 1986, Zentralblatt fur Chirurgie,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Refractory vasospasm occurring in a trauma patient receiving dihydroergotamine and heparin.
September 1988, Critical care medicine,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Severe arterial and venous thrombosis in a patient with heparin-induced thrombocytopenia type II.
May 1997, Intensive care medicine,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Onset of neurologic deficits after treatment with dihydroergotamine in a patient with sagittal sinus thrombosis.
April 1996, Clinical neuropharmacology,
I Magnusson, and K G Kulling, and F Lund, and F Magaard, and K Stånge, and S Törngren
Severe vasospastic reactions (ergotism) during prophylactic administration of heparin-dihydroergotamine.
January 1987, VASA. Zeitschrift fur Gefasskrankheiten,
Copied contents to your clipboard!